Azienda Ospedaliero Universitaria Parma - SC Oncologia Medica

Parma, Emilia-Romagna 43126

1 studies enrolling now · 1 studies all time

What they study most

Advanced Non-small Cell Lung Cancer, EGFR Mutation, HER2 Mutation

Studies at this site

• First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Epidermal Growth Factor Receptor (EGFR) and/or Human Epidermal Growth Factor Receptor 2 (HER2) — Recruiting now